2021-04-01T11:58:11Z
2021-04-01T11:58:11Z
2020-08
2021-04-01T11:58:11Z
Chagas disease is emerging in countries to which it is not endemic. Biomarkers for earlier therapeutic response assessment in patients with chronic Chagas disease are needed. We profiled plasma-derived extracellular vesicles from a heart transplant patient with chronic Chagas disease and showed the potential of this approach for discovering such biomarkers.
Article
Versió publicada
Anglès
Malaltia de Chagas; Plasma sanguini; Marcadors bioquímics; Chagas' disease; Blood plasma; Biochemical markers
Centers for Disease Control and Prevention
Reproducció del document publicat a: https://doi.org/10.3201/eid2608.191042
Emerging Infectious Diseases, 2020, vol. 26
https://doi.org/10.3201/eid2608.191042
Domini públic / Public domain
http://creativecommons.org/publicdomain/zero/1.0/